Is there a possibility of benign lesions in pulmonary IAC?

Lung IAC generally has no benign possibility. Lung IAC refers to the pathological stage of invasive adenocarcinoma of the lung. Invasive pulmonary adenocarcinoma is a malignant tumor in which cancer cells invade and infiltrate surrounding lung tissues, representing a relatively severe lung disease.

Lung IAC is an abbreviation for the pathological type of lung cancer, specifically meaning invasive adenocarcinoma of the lung. Pathologically, lung adenocarcinoma is classified into adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive adenocarcinoma. IAC, the English acronym for invasive adenocarcinoma, results from the progression of adenocarcinoma in situ and minimally invasive adenocarcinoma. Generally, this type of adenocarcinoma is not highly sensitive to radiotherapy and chemotherapy, but it is prone to genetic mutations. Appropriate targeted drugs can be administered based on the specific gene mutation sites, often yielding favorable outcomes.

If IAC is present, it indicates that the tumor has significantly broken through the basement membrane, with accelerated growth and an increased likelihood of metastasis. For patients with lung cancer, regular follow-up examinations are recommended according to a defined schedule. These checkups typically include chest CT, neck ultrasound, abdominal ultrasound, bone scans, brain CT, tumor markers, and other routine biochemical tests, allowing dynamic monitoring of the disease and early detection of signs of recurrence.

Upon diagnosis of invasive pulmonary adenocarcinoma, patients should maintain a positive mindset, avoid excessive anxiety, and actively cooperate with the treatment plan prescribed by their physician to control further spread of cancer cells.